- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 127,990 | 28.06.24 21:15:52 | -1,830 | -1,41% | 127,980 | 128,000 | 131,990 | 129,820 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 83,800 | 28.06.24 21:11:09 | +1,470 | +1,79% | 83,660 | 83,890 | 82,720 | 82,330 |
